Arjowiggins and Meeschaert Private Equity have announced the planned sale of Arjowiggins Healthcare to Meeschaert Private Equity in partnership with the company’s executive management team.

Information/consultation procedures have been initiated with the relevant personnel works councils and the transaction should be finalised by the end Q2 2016.

Arjowiggins Healthcare has leading positions in sterile packaging solutions via the Sterimed and Sterisheet brands. It produces and converts the papers and substrates used to package sterile medical devices such as syringes, healthcare kits, gowns, drapes, gauzes and catheters. With offices in four countries (France, USA, Czech Republic and China), with a consolidated turnover of €75 million, Arjowiggins Healthcare employs over 330 people and delivers to hospitals, medical device manufacturers and special packaging players in over 70 countries.

Meeschaert Private Equity specializes in investment in unlisted, socially responsible SMEs. It aids management in thestrategic transformation of their companies and support them in their development.

Olswang France LLP is advising Arjowiggins. The team is led by Corporate Partner Guillaume Kessler with support from Associates Stanislas Marmion and Caroline Pucel, Lisa Varela; Partner Julien Monsenego and Senior Associate Laurent Ragot (Tax); as well as Partner Karine Audouze and Senior Associate Amandine Racé (Employment).

DLA Piper is advising Meeschaert Private Equity with Corporate Partner Jérémy Scemama and Associate Amale El Fatmioui; Partner Jérôme Halphen and Associate Vanessa Li (Employment); and Partner Karine Disdier-Mikus and Associate Gaspard Debiesse (Intellectual Property).

Tax aspects are provided by Arsene Taxand and are led by Partner Franck Chaminade, Senior Associate Charles Dalarun and Associate Virginie Leprizé.

The management is advised by Partner Lucas d'Orgeval and Charlotte Hazan from Vergnaud d'Orgeval.